Médicaments (11941)

This tender for pharmaceutical products is generally well-structured with clear basic information and available documents. However, it lacks specific details on evaluation criteria and technical/eligibility requirements, impacting clarity and completeness.

The tender adheres to general EU procurement directives (Code: 2014/24/ES) and uses a proper CPV code. Deadlines appear reasonable for an open procedure, and there are no immediate indications of disputes. The procedure is clearly defined as 'OPEN'.

The description of the procurement ('various pharmaceutical products') is concise. While essential documents like technical specifications and contract drafts are available, the absence of specified evaluation criteria and detailed eligibility/technical requirements leaves room for interpretation.

Most basic information is present, including estimated value, contract duration, and a submission deadline. However, the AI-extracted requirements section is largely empty, suggesting that detailed mandatory exclusion grounds, eligibility, technical, and financial requirements might be missing or not easily extractable from the provided documents.

The tender is an open procedure, promoting broad participation. Access to documents is implied through the list provided. The estimated value is disclosed, and criteria for evaluation are expected to be in the documents. There are no obvious signs of tailoring requirements to specific companies.

The tender is marked as 'E-Procurement', suggesting electronic submission is possible. However, the 'No e-submission' flag in the checks section contradicts this, creating ambiguity. The contract start date is not explicitly stated, and financing information is absent.

Key fields like title, reference, organization, value, and deadlines are populated. The status is 'active', and there are no reported disputes or suspensions. Dates are logically ordered.

There is no explicit mention of green procurement, social aspects, or innovation within the provided information. The tender is not flagged as EU funded.